Not currently recruiting at University of California Health
COVID Protection After Transplant - Sanofi GSK (CPAT-SG) Study
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSD UCSF
- Dates
- study startedestimated completion
- Principal Investigator
- by Saima Aslam, MBBS (ucsd)Monica Fung, MD (ucsf)
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientists at University of California Health
- Saima Aslam, MBBS (ucsd)
Clinical Professor, Medicine, Vc-health Sciences-schools. Authored (or co-authored) 83 research publications - Monica Fung, MD (ucsf)
Monica Fung specializes in infectious diseases with a focus on patients with compromised immune systems, including those with solid organ or stem cell transplants. She attends on the Immunocompromised and General Infectious Diseases Consult Services, and has clinics in the 360 Wellness Center and Infectious Diseases Faculty Practice at UCSF-Parnassus.
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Links
- National Institute of Allergy and Infectious Diseases (NIAID) Division of Allergy, Immunology, and Transplantation (DAIT)
- ID
- NCT05518487
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 80 study participants
- Last Updated